# Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy

> **NCT00490490** · PHASE2 · TERMINATED · sponsor: **Stanford University** · enrollment: 8 (actual)

## Conditions studied

- Lymphoma, Non-Hodgkin

## Interventions

- **DRUG:** Bexxar (tositumomab)
- **PROCEDURE:** External beam radiotherapy (XRT)
- **DRUG:** Potassium Iodide (KI)

## Key facts

- **NCT ID:** NCT00490490
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01
- **Primary completion:** 2011-06
- **Final completion:** 2013-07
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Low Accrual
- **Last updated:** 2017-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00490490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00490490, "Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00490490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*